Peter Bertinato
About Peter Bertinato
Peter Bertinato is a seasoned Director of Medicinal Chemistry with over 25 years of experience in drug discovery and development, and has contributed to the discovery of several drug candidates, including the FDA-approved SelentrolTM.
Peter Bertinato's Professional Title
Peter Bertinato currently holds the position of Director of Medicinal Chemistry. In this role, he brings his extensive expertise in drug discovery and development to the forefront, guiding research and development teams towards successful drug candidates.
Peter Bertinato's Experience in Drug Discovery and Development
With over 25 years of experience in the pharmaceutical industry, Peter Bertinato has significantly contributed to the field of drug discovery and development. He has been involved in the discovery of numerous preclinical and clinical drug candidates. His work includes contributions to the development of SelentrolTM, an FDA-approved veterinary medicine.
Peter Bertinato's Role at Reverie Labs
At Reverie Labs, Peter Bertinato served as the Director of Medicinal Chemistry. During his tenure, he led teams in the pursuit of innovative medicinal solutions, leveraging his vast experience to drive the company’s research and development initiatives.
Peter Bertinato's Previous Positions at Major Pharmaceutical Companies
Peter Bertinato has held several senior scientist roles at leading pharmaceutical companies, including Eisai, Epix, and Pfizer. His work at these organizations has been instrumental in advancing pharmaceutical research and development, contributing to the discovery and progression of multiple drug candidates.
Peter Bertinato's Consultancy Work
Peter Bertinato has also provided consultancy services to several small biotech companies and the Cystic Fibrosis Foundation. His insights and expertise have supported these organizations in their quests to develop new and effective drug therapies.